Close X
Saturday, September 21, 2024
ADVT 
International

WHO worried about surge of COVID in China amid lack of info

Darpan News Desk The Canadian Press, 04 Jan, 2023 12:07 PM
  • WHO worried about surge of COVID in China amid lack of info

GENEVA (AP) — The head of the World Health Organization said Wednesday the agency is “concerned about the risk to life in China” amid the coronavirus’ explosive spread across the country and the lack of outbreak data from the Chinese government.

WHO Director-General Tedros Adhanom Ghebreyesus said the agency recently met with Chinese officials to underline the importance of sharing more details about COVID-19 issues including hospitalization rates and genetic sequences, even as the pandemic continues to recede globally since it began in late 2019.

“Data remains essential for WHO to carry out regular, rapid and robust risk assessments of the global situation,” Tedros said at a press briefing.

Tedros said he understood why numerous countries have recently taken measures against travelers coming from China, saying “it’s understandable that some countries are taking steps to prevent their citizens” given the void of information about COVID-19.

WHO emergencies chief Dr. Michael Ryan said the testing protocols implemented by some countries were not a restriction against travel.

“It's not an excessive measure based on individual countries' risk assessment,” Ryan said.

He noted that for the past three years, China has had some of the world's harshest rules regarding COVID-19. “The reality for China is that many countries (now feel) they don’t have enough information to base their risk assessment,” he said.

Earlier this week, Chinese officials sharply criticized COVID-19 testing requirements imposed on visitors from China and threatened countermeasures against countries involved, which include the U.S. and several European nations.

“We believe that the entry restrictions adopted by some countries targeting China lack scientific basis, and some excessive practices are even more unacceptable,” Foreign Ministry spokesperson Mao Ning said at a briefing Tuesday.

The WHO's Ryan added that there were continuing concerns about how Chinese officials are recording coronavirus deaths, saying that their definition, which only counts COVID-19 deaths if there is a record of respiratory failure, is too narrow.

Throughout December, China recorded only 13 official COVID-19 deaths, despite many thousands of cases every day and reports about overwhelmed hospitals, fever clinics and crematoriums.

A WHO expert group said Wednesday that no worrying new COVID variants have been identified in China based on the information authorities have shared, including genetic sequences deposited into a public database. The WHO said Chinese scientists have now shared more than 770 sequences, with omicron subvariants BA.5 and its descendants accounting for more than 97% of all local infections. Globally, BA.5 variants comprise about 68% of all sequences.

The European Centre for Disease Prevention and Control said it did not expect the surge of COVID-19 in China to affect the outbreak in Europe, given the high rates of vaccination across the continent. It also noted that the variants spreading in China were already present in Europe, suggesting that any spillover from China would have a negligible impact.

Maria Van Kerkhove, the WHO’s technical lead on COVID-19, said the agency was currently evaluating the significance of the variant known as XBB.1.5, which has recently comprised an increasing proportion of cases in the U.S.

“Our concern is how transmissible it is,” Van Kerkhove said. “The more this virus circulates, the more chances it will have to change,” she said, adding that further waves of transmission do not necessarily have to translate into more deaths, with the wide availability of vaccination and drugs.

Van Kerkhove said there is no data yet to prove that XBB.1.5 causes more severe disease, but that the WHO is working on a new risk assessment of the variant that it expects to release soon.

___

Follow AP’s coverage of the pandemic at https://apnews.com/hub/coronavirus-pandemic

MORE International ARTICLES

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent
Announcing the results on Monday, Moderna said it has submitted emergency use authorisation from the US Food and Drug Administration (FDA), to apply for a conditional marketing authorisation with the European Medicines Agency (EMA) and to progress with the rolling reviews, which have already been initiated with international regulatory agencies.

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

WATCH: Why are Farmers Up in Arms Against India's Government ?

WATCH: Why are Farmers Up in Arms Against India's Government ?
Protest by thousands of farmers from Punjab and Haryana took place in New Delhi over the weekend entering its fifth day Monday as the farmers continue to showcase their displeasure against the Centre's new farm laws. 

WATCH: Why are Farmers Up in Arms Against India's Government ?

White House still planning holiday parties, despite warnings

White House still planning holiday parties, despite warnings
Monday's delivery of an 18-and-a-half foot tall Fraser fir by horse-drawn carriage signalled the kickoff of the usual array of White House holiday events that will include the annual turkey pardon and Christmas and Hanukkah events.

White House still planning holiday parties, despite warnings

3rd major COVID-19 vaccine shown to be effective and cheaper

3rd major COVID-19 vaccine shown to be effective and cheaper
The results are based on an interim analysis of trials in the U.K. and Brazil of a vaccine developed by Oxford University and manufactured by AstraZeneca.

3rd major COVID-19 vaccine shown to be effective and cheaper

Pfizer seeking emergency use of its COVID-19 vaccine in US

Pfizer seeking emergency use of its COVID-19 vaccine in US
The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.

Pfizer seeking emergency use of its COVID-19 vaccine in US

Some of Trump's trade legacy to linger under Biden

Some of Trump's trade legacy to linger under Biden
Future administrations, be they Democrat or Republican, are unlikely to forget the lessons of 2016 any time soon, a panel of trade experts agreed Thursday.

Some of Trump's trade legacy to linger under Biden